Site icon South Africa Gateway

AstraZeneca Covid vaccine withdrawn because it’s outdated – not for ‘dangerous side effect’

AstraZeneca Covid vaccine withdrawn because it’s outdated – not for ‘dangerous side effect’

Pharma giant AstraZeneca has acknowledged the rare side effect of its coronavirus vaccine for years. The drug has now been withdrawn simply because it can’t compete with newer and better alternatives.


MARY ALEXANDER • 21 MAY 2024
Published by Africa Check on 6 June 2024


“AstraZaneca Covid 19 vaccine withdrawn worldwide after manufacturers admitted it can cause dangerous side effect,” reads a claim circulating on social media in Ghana and elsewhere in May 2024.*

The vaccine was developed at the UK’s Oxford University in the first year of the Covid pandemic, in collaboration with the pharma company AstraZeneca. Its generic name is ChAdOx1-S and its brand names Covishield and Vaxzevria.

It’s been used in more than 100 countries across the world, with some 3 billion jabs given. In February 2021 the West African country of Ghana was the first on the continent to roll out, under the Covax facility, what was then known as the AstraZeneca/Oxford vaccine.

Many versions of the claim use a graphic showing a vial of vaccine and the text: “AstraZeneca Covid vaccine withdrawn worldwide, months after its manufacturers admitted the vaccine can cause a rare and dangerous side effect.”

The graphic includes the logo of TV3 Ghana, while the text is credited to the Telegraph, a UK newspaper. In Ghana, it’s been posted with comments such as:

Other versions of the claim link to the Telegraph article.

When it was first published on 7 May, the article’s headline read: “AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect.”

It’s since been altered to read: “AstraZeneca withdrawing Covid vaccine worldwide.” No reason for the change is given.

Some online users have taken the claim further, saying that the vaccine has been withdrawn due to a “rare and severe side effect”.

The claim can also be seen here, here, here, here, here, here, here and here.

AstraZeneca has withdrawn its Covid vaccine, voluntarily. And the vaccine does have a rare and sometimes fatal side effect.

But the side effect, which the company has acknowledged for years, has nothing to do with the vaccine’s withdrawal.

Side effect identified in 2021, noted in package inserts

The AstraZeneca vaccine’s most severe side effect is thrombosis with thrombocytopenia syndrome, or TTS. Thrombosis is a blood clot in the blood vessels or the heart, which can lead to stroke, heart attack or an embolism in the lungs. Thrombocytopenia is a low platelet count in the blood.

TTS is rare, occurring in two to three people for every 100,000 who got the jab. When it has occurred, it has led to death in a range from 5% to 50% of cases.

On the other hand, it’s been independently estimated that the AstraZeneca Covid vaccine saved more than 6 million lives during its first year of use.

In April 2024 the Telegraph reported that “AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time”.

But this is misleading. All it says is that AstraZeneca has acknowledged the TTS side effect for the first time in court documents.

The company is currently facing a class action suit in the UK from families of people who have died from TTS, and others who claim to have been disabled by the vaccine.

AstraZeneca’s submission was made to the UK high court in February. The Telegraph quotes it:

It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known. Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence.

TTS was first identified as a possible side effect of the AstraZeneca vaccine in March and April 2021. This was after the conclusion of the vaccine’s clinical trials, which tested it on some 60,000 people.

From April 2021 warnings about TTS as a side effect were included in package inserts and other patient information about the vaccine – here, here, here, here, here and here. It was also mentioned in AstraZeneca’s 2021 annual report.

The company has acknowledged the side effect since it was first identified three years ago.

Outcompeted and outdated

In March 2024 AstraZeneca applied to have the vaccine’s European Union marketing authorisation withdrawn, which was approved on 7 May. The vaccine is no longer manufactured or sold, and has been withdrawn across the world.

The vaccine was developed to combat the original Wuhan strain of the coronavirus and has not been updated. This means it is less effective against new variants of the virus. South Africa, for example, withdrew it in early 2021 because it gave little protection against the mutated Beta variant of the virus, then dominant in the country.

In a May 2024 statement, AstraZeneca said: “As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria.”

Several experts have backed this up, saying that with lower demand for Covid vaccines and more effective options available, AstraZeneca no longer has any commercial reason to manufacture and distribute the jab.

AstraZeneca has withdrawn its vaccine because it’s out of date and can’t compete, not because of the long-identified TTS side effect.

The vaccine has been a target of misinformation from the start – and to the end.


* Some Facebook and Instagram users may have deleted their posts after Meta’s Third-Party Fact-Checking Program rated their claims as untrue.

Exit mobile version